Girgis Obaid

Assistant Professor - Bioengineering

Dr. Girgis Obaid's lab integrates nanotechnology, immunoengineering and light-activated “photodynamic” therapy to develop new ways to treat stubborn pancreas cancer and cancers of the head and neck. Dr. Obaid's research is supported by the NIH, NSF and CPRIT.

+1 (972) 883 - 7375
BSB15.510
Obaid Lab Research
Obaid Lab Team
ORCID

About Girgis Obaid

Publications

Image‐based treatment planning for TLD1433 mediated intraoperative photodynamic therapy with an optical surface applicator—A translational rodent study 2025 - Journal Article

Fine-Tuning Photochemical Immunogenic Cell Death by a Panel of Verteporfin-Lipid Nanoparticles: A Data-Driven Approach. 2025 - Journal Article

Predicting head and neck tumor nodule responses to TLD1433 photodynamic therapy using the image-guided surgery probe ABY-029. 2025 - Journal Article

Recent strides in macromolecular targeted photodynamic therapy for cancer 2024 - Journal Article

Increasing the Dye Payload of Cetuximab-IRDye800CW Enables Photodynamic Therapy. 2024 - Journal Article

PD-L1 Immune Checkpoint Targeted Photoactivable Liposomes (iTPALs) Prime the Stroma of Pancreatic Tumors and Promote Self-Delivery. 2024 - Journal Article

A single photodynamic priming protocol augments delivery of ⍺‐PD‐L1 mAbs and induces immunogenic cell death in head and neck tumors 2024 - Journal Article

A Physiochemical, In Vitro, and In Vivo Comparative Analysis of Verteporfin–Lipid Conjugate Formulations: Solid Lipid Nanoparticles and Liposomes 2024 - Journal Article